According to filings with the U.S. Securities and Exchange Commission, Epicore Biosystems is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Roozbeh Ghaffari played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Epicore Biosystems
Epicore Biosystems, Inc. has developed a proprietary sweat microfluidic sensing platform that is skin-like, low-cost, and capable of analyzing small droplets of sweat directly from the skin. This technology is based on over two decades of microfluidic and soft materials research in Prof. John Rogers? Laboratory at Northwestern Universitys Center for Bio-Integrated Electronics. Epicore Biosystems recently signed a partnership with a leading Fortune 100 global brand to commercialize the first-ever, single-use sweat analytics system for athletes. The companys sweat microfluidic platform has been deployed with professional sports teams (NBA, NFL, and MLB), military research labs, and across multiple clinical study programs, including stroke, skin health, stress, fatigue, and kidney health.

To learn more about Epicore Biosystems, visit http://www.epicorebiosystems.com/

Contact:
Roozbeh Ghaffari, President and Chief Executive Officer
617-251-3686
https://www.linkedin.com/in/roozbeh-ghaffari-3289341/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.